Question 24090 — pharmacy and medications

Summary

Ms. Marie-Pierre Rixain draws the attention of the Minister of Solidarity and Health to the accessibility of Naloxone. In 2017, Naloxone (specific antidote for opioid overdoses) began to be made available to opioid users and their entourage in order to enable rapid intervention in the event of an overdose, while awaiting assistance, following the recommendations of the World Health Organization. This palliative allows effectively combat addiction to opioids, the consumption of which, as well as the associated risks, are increasing rapidly. However, its availability is problematic. Indeed, we still deplore the lack of information and knowledge among doctors regarding this palliative: few know that the treatment can be prescribed by all doctors and that it is freely available in pharmacies. Not to mention that, according to a recent survey, out of 80 pharmacies selected in 7 cities in France, only two had the kit for sale and 20 offered to order it from the laboratory, the others not finding it on their wholesaler's software. From then on, she asked him about the measures to be taken to facilitate the general public's knowledge of and access to Naloxone.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.